Hemostasis Today

September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
Aug 11, 2026, 15:25

Bradley Maron։ The AI Revolution in Cardiovascular Drug Development

Bradley Maron, Editor-in-Chief of Circulation at American Heart Association, shared a post on LinkedIn about a recent article by Jake Silberg, published in Circulation, adding:

”This Week in Circulation:

This week’s feature on agentic and generative AI in drug discovery is already generating real conversation — including from the authors themselves.

Dr. James Zou and colleagues discuss how AI is changing therapeutic development. They break down a complicated topic into clear terms — extremely exciting, and extremely relevant to cardiovascular medicine.

The piece walks through how AI is starting to reshape three key stages of cardiovascular drug development: target selection, therapeutic design, and clinical trial recruitment. Congratulations to Jake Silberg, Peter Eckmann, Joseph Boen, and James Zou on a piece that’s clearly striking a nerve with the field.

Here’s why it matters: the tools are early, and the authors are candid about that — but the direction of travel is one every translational scientist should be watching.”

Title: Agentic and Generative AI for Drug Discovery

Authors: Jake Silberg, Peter Eckmann, Joseph Boen, James Zou

Bradley Maron։ The AI Revolution in Cardiovascular Drug Development

Stay updated on all scientific advances with Hemostasis Today.